Energetics in colorectal and prostate cancer.
暂无分享,去创建一个
[1] Stacey A. Kenfield,et al. Diet and Lifestyle Interventions in Active Surveillance Patients with Favorable-Risk Prostate Cancer , 2007, Current treatment options in oncology.
[2] J. Meyerhardt,et al. Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] C. Friedenreich,et al. A randomized trial of exercise and quality of life in colorectal cancer survivors. , 2003, European journal of cancer care.
[4] Dallas R. English,et al. Body size and composition and prostate cancer risk: systematic review and meta-regression analysis , 2006, Cancer Causes & Control.
[5] C. Friedenreich,et al. Physical activity and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort , 2009, International journal of cancer.
[6] K. Courneya,et al. Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] J. Stanford,et al. Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle‐aged men , 2007, Cancer.
[8] I. Bairati,et al. Dietary fat and prostate cancer survival , 1999, Cancer Causes & Control.
[9] G. Colditz,et al. Physical activity and colon cancer prevention: a meta-analysis , 2009, British Journal of Cancer.
[10] A. Haese*,et al. Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy. , 2007, European journal of cancer.
[11] K. Courneya,et al. Cancer survivors' adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society's SCS-II. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] D. English,et al. Physical activity, insulin-like growth factor 1, insulin-like growth factor binding protein 3, and survival from colorectal cancer , 2005, Gut.
[13] D. Kuban,et al. Influence of obesity on biochemical and clinical failure after external‐beam radiotherapy for localized prostate cancer , 2006, Cancer.
[14] N. Mendell,et al. Intensive lifestyle changes may affect the progression of prostate cancer. , 2005, The Journal of urology.
[15] M. Cooperberg,et al. Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE. , 2005, Urology.
[16] J. Aitken,et al. Associations of leisure-time physical activity with quality of life in a large, population-based sample of colorectal cancer survivors , 2007, Cancer Causes & Control.
[17] S. Bertrais,et al. Influence of dietary factors on colorectal cancer survival , 2003, Gut.
[18] K. Chapman,et al. A systematic review of the effect of diet in prostate cancer prevention and treatment. , 2009, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.
[19] P. Carroll,et al. Clinical events in prostate cancer lifestyle trial: results from two years of follow-up. , 2008, Urology.
[20] T. Marshall,et al. A meta‐analysis of the association of physical activity with reduced risk of colorectal cancer , 2005, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[21] E. Ponce,et al. World Cancer Research Fund, American Institute for Cancer Research. Second Expert Report, Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective. United Kingdom: WCRF/AICR, 2001 , 2009 .
[22] D. Sargent,et al. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] S. Stroup,et al. Effect of obesity on prostate‐specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 Radiation Therapy Oncology Group‐American Society for Therapeutic Radiation and Oncology (RTOG‐ASTRO) Phoenix consensus definition , 2007, Cancer.
[24] E. Jung,et al. Visceral Obesity May Affect Oncologic Outcome in Patients with Colorectal Cancer , 2008, Annals of Surgical Oncology.
[25] Z. Nahleh,et al. Residual cancer burden in locally advanced breast cancer: a superior tool , 2008, Current oncology.
[26] M. Cooperberg,et al. National practice patterns and time trends in androgen ablation for localized prostate cancer. , 2003, Journal of the National Cancer Institute.
[27] J. Meyerhardt,et al. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] A. D'Amico,et al. Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] K. Wallner,et al. Obesity Is Not Predictive of Overall Survival Following Permanent Prostate Brachytherapy , 2007 .
[30] M. Kattan,et al. Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy , 2005, Cancer.
[31] C. Friedenreich,et al. Physical exercise and quality of life following cancer diagnosis: A literature review , 1999, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.
[32] Carmen Rodriguez,et al. Body Mass Index, Weight Change, and Risk of Prostate Cancer in the Cancer Prevention Study II Nutrition Cohort , 2007, Cancer Epidemiology Biomarkers & Prevention.
[33] M. Parmar,et al. The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer. , 2001, The Journal of clinical endocrinology and metabolism.
[34] W. Catalona,et al. Does body mass index affect preoperative prostate specific antigen velocity or pathological outcomes after radical prostatectomy? , 2007, Journal of Urology.
[35] M. Terris,et al. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. , 2007, JAMA.
[36] A. Kibel. Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy for Prostate Cancer , 2007 .
[37] J. Meyerhardt,et al. Influence of body mass index on outcomes and treatment‐related toxicity in patients with colon carcinoma , 2003, Cancer.
[38] A. Williams,et al. Nutrition During and After Cancer Treatment: A Guide * for Informed Choices by Cancer Survivors , 2001, CA: a cancer journal for clinicians.
[39] H. Sandler,et al. Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] S. Fosså,et al. A systematic review of physical activity in prostate cancer survivors: outcomes, prevalence, and determinants , 2008, Supportive Care in Cancer.
[41] A. Kristal,et al. Anthropometrics and prostate cancer risk. , 2007, American journal of epidemiology.
[42] N. Barnard,et al. Diet and survival after prostate cancer diagnosis. , 2007, Nutrition reviews.
[43] M. Stampfer,et al. Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. , 2008, The Lancet. Oncology.
[44] Yan Liu,et al. Risk factors for prostate cancer incidence and progression in the health professionals follow‐up study , 2007, International journal of cancer.
[45] D. Albanes,et al. Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality , 2007, Cancer.
[46] Matthew R. Smith. Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer. , 2004, Urology.
[47] M. Terris,et al. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[48] A. Jemal,et al. Global Cancer Statistics , 2011 .
[49] A. Dobs,et al. Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen‐deprivation therapy , 2006, Cancer.
[50] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[51] H. Sandler,et al. Obesity and mortality in men with locally advanced prostate cancer , 2007, Cancer.
[52] A. Trentham-Dietz,et al. Physical activity and function in older, long-term colorectal cancer survivors , 2009, Cancer Causes & Control.
[53] Timothy F. Donahue,et al. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[54] M. Terris,et al. Obesity and oncological outcome after radical prostatectomy: impact of prostate‐specific antigen‐based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center Databases , 2008, BJU international.
[55] W. Willett,et al. Physical activity and male colorectal cancer survival. , 2009, Archives of internal medicine.
[56] Tim Byers,et al. Nutrition and Physical Activity During and After Cancer Treatment: An American Cancer Society Guide for Informed Choices , 2003, CA: a cancer journal for clinicians.
[57] K. Do,et al. Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.
[58] M. Forman,et al. Saturated fat intake predicts biochemical failure after prostatectomy , 2008, International journal of cancer.
[59] E. Giovannucci. Diet, body weight, and colorectal cancer: a summary of the epidemiologic evidence. , 2003, Journal of women's health.
[60] J. Goodwin,et al. Increasing use of gonadotropin‐releasing hormone agonists for the treatment of localized prostate carcinoma , 2005, Cancer.
[61] P. Carroll,et al. The impact of obesity on overall and cancer specific survival in men with prostate cancer. , 2009, The Journal of urology.
[62] J. Meyerhardt,et al. Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[63] K. Courneya,et al. Associations Between Exercise, Quality of Life, and Fatigue in Colorectal Cancer Survivors , 2008, Diseases of the colon and rectum.
[64] E. Guns,et al. Diet and dietary supplement intervention trials for the prevention of prostate cancer recurrence: a review of the randomized controlled trial evidence. , 2008 .
[65] B. Leibovich,et al. Obesity and survival after radical prostatectomy: A 10‐year prospective cohort study , 2006, Cancer.
[66] W. Willett,et al. Comparison of risk factors for colon and rectal cancer , 2004, International journal of cancer.
[67] D. English,et al. Effect of physical activity and body size on survival after diagnosis with colorectal cancer , 2005, Gut.
[68] D. Dunger,et al. Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. , 2002, Journal of the National Cancer Institute.
[69] N. Wolmark,et al. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. , 2006, Journal of the National Cancer Institute.
[70] Anthony L Zietman,et al. Changes in body composition during androgen deprivation therapy for prostate cancer. , 2002, The Journal of clinical endocrinology and metabolism.
[71] F. Montorsi,et al. Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men , 2007, International journal of cancer.
[72] W. Demark-Wahnefried. Dietary interventions in prostate cancer , 2008, Current urology reports.
[73] J. Meyerhardt,et al. Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[74] S. Basaria,et al. Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis. , 2008, The Journal of clinical endocrinology and metabolism.
[75] Graham A Colditz,et al. Physical activity and survival after colorectal cancer diagnosis. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[76] P. Tartter,et al. Cholesterol, weight, height, quetelet's index, and colon cancer recurrence , 1984, Journal of surgical oncology.
[77] C. Friedenreich,et al. Relationship between exercise pattern across the cancer experience and current quality of life in colorectal cancer survivors. , 1997, Journal of alternative and complementary medicine.
[78] F. Hu,et al. Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. , 2007, JAMA.
[79] C. Friedenreich,et al. The Colon Health and Life-Long Exercise Change trial: a randomized trial of the National Cancer Institute of Canada Clinical Trials Group , 2008, Current oncology.
[80] S. Tyldesley,et al. Obesity as a predictor of biochemical recurrence and survival after radiation therapy for prostate cancer , 2007, BJU international.
[81] A. Jemal,et al. Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.
[82] D. Smith,et al. Chemotherapy for hormone refractory prostate cancer. , 1999, The Urologic clinics of North America.
[83] M. Slattery,et al. Diet and survival of patients with colon cancer in Utah: is there an association? , 1989, International journal of epidemiology.
[84] C. Bulpitt,et al. Testosterone suppression in men with prostate cancer leads to an increase in arterial stiffness and hyperinsulinaemia. , 2003, Clinical science.